Viatris Aktie

Viatris für 0 Euro bei ZERO ordern (zzgl. Spreads)

WKN DE: A2QAME / ISIN: US92556V1061

<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>
08.05.2025 14:23:33

Viatris Boosts FY25 Adj. EPS Outlook - Update

(RTTNews) - While reporting financial results for the first quarter on Thursday, healthcare company Viatris Inc. (VTRS) raised its adjusted earnings guidance for the full-year 2025, while maintaining annual revenue outlook.

For fiscal 2025, the company now projects adjusted earnings in a range of $2.16 to $2.30 per share, up from the prior guidance range of $2.12 to $2.26 per share. Total revenues are still expected between $13.50 billion and $14.00 billion.

On average, seven analysts polled expect the company to report earnings of $2.21 per share on net sales of $13.82 billion for the year. Analysts' estimates typically exclude special items.

The company is also reaffirming its plans to prioritize capital return in 2025, including $500 million to $650 million in share repurchases.

For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com

Analysen zu Viatris Inc Registered Shsmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Viatris Inc Registered Shs 7,87 0,48% Viatris Inc Registered Shs